Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Price:
24.51 USD
2.51%
Market Closed
Updated:
Jun 11, 2024
Arrowhead Pharmaceuticals Inc
Total Liabilities
|
Arrowhead Pharmaceuticals Inc
Total Liabilities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
Total Liabilities
$471.4m
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
45%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$140.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$38.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$88B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$5.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
See Also
What is Arrowhead Pharmaceuticals Inc's Total Liabilities?
Total Liabilities
471.4m
USD
471.4m
USD
Based on the financial report for Mar 31, 2024, Arrowhead Pharmaceuticals Inc's Total Liabilities amounts to 471.4m USD.
What is Arrowhead Pharmaceuticals Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
45%
45%
Over the last year, the Total Liabilities growth was 6%. The average annual Total Liabilities growth rates for Arrowhead Pharmaceuticals Inc have been 15% over the past three years , 29% over the past five years , and 45% over the past ten years .
You don't have any saved screeners yet
